Pharmacogenomics integrates genomic information into drug development processes, aiming to create more effective and personalized therapies. This book explores the role of pharmacogenomics in the early stages of drug discovery, including target identification, lead optimization, and preclinical testing. It discusses how genetic variations influence drug response, efficacy, and safety, enabling the design of drugs tailored to specific genetic profiles. Designed for pharmaceutical scientists, geneticists, and drug development professionals, it highlights the transformative impact of pharmacogenomics on developing precision medicines and improving therapeutic outcomes.
Brian Green integrates pharmacogenomics into the drug development process to create personalized dermatological treatments. His research focuses on how genetic variations influence the efficacy and safety of new skin medications. Brian has authored numerous studies on using genetic data to guide the design and testing of dermatological drugs. He also offers guidelines for pharmaceutical researchers to incorporate pharmacogenomic insights into developing effective and personalized dermatological therapies, promoting precision medicine in drug development.